Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07543965 · ClinicalTrials.gov registry record
Cohort of Repeat Donor Experiences (CORE) Study
A clinical trial, sponsored by Westat.
- Not yet
- Registry status
- 2,090
- Enrollment target
NCT07543965 is a clinical trial that has not yet begun recruiting, run by Westat. The registered enrollment target is 2,090 participants.
The verdict
NCT07543965 has not yet begun recruiting, sponsored by Westat.
- NOT YET RECRUITING
- Registry status
- 2,090 participants
- Enrollment target
Study Summary
The Plasma Protein Therapeutics Association (PPTA) sponsors the Cohort of Repeat Donor Experiences (CORE) Study. This is a prospective, observational cohort study that will follow Source Plasma donors for up to 2 years during the main study (anticipated to begin in summer 2026) and up to 3 months during the pilot launching in mid-March 2026. This study aims to confirm a lack of negative health effects Source Plasma donors may experience as a result of frequent plasmapheresis. The study will use data obtained through self-report surveys for the duration of the study along with periodic whole blood sample collections to test for CRP, ferritin, and IgG.
Interventions
- PROCEDURE Plasmapheresis Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,090 participants |
| Start Date | 2026-04-06 |
| Est. Completion | 2029-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07543965
The ClinicalTrials.gov registry entry for NCT07543965 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 2,090 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Westat, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Plasmapheresis Procedure is the first listed.
NCT07543965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07543965 about?
NCT07543965 is a clinical study titled "Cohort of Repeat Donor Experiences (CORE) Study". The Plasma Protein Therapeutics Association (PPTA) sponsors the Cohort of Repeat Donor Experiences (CORE) Study. This is a prospective, observational cohort study that will follow Source Plasma donors for up to 2 years during the main study (anticipated to begin in summer 2026) and up to 3 months du...
What is the current status of trial NCT07543965?
This trial is currently not yet recruiting. The enrollment target is 2,090 participants. The study started on 2026-04-06. Estimated completion is 2029-04-30.
What interventions are being tested in trial NCT07543965?
The interventions under investigation include: Plasmapheresis Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT07543965?
This trial is sponsored by Westat, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.